Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 16 (1) , 68-74
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- The Phenotypic Expression of Inflammatory Bowel Disease in Patients with Primary Sclerosing Cholangitis Differs in the Distribution of ColitisDigestive Diseases and Sciences, 2013
- High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasiaAlimentary Pharmacology & Therapeutics, 2012
- High-Dose Ursodeoxycholic Acid Is Associated With the Development of Colorectal Neoplasia in Patients With Ulcerative Colitis and Primary Sclerosing CholangitisAmerican Journal of Gastroenterology, 2011
- Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2011
- Primary sclerosing cholangitis: overview and updateNature Reviews Gastroenterology & Hepatology, 2010
- Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)Gut, 2010
- Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformationLaboratory Investigation, 2008
- Bile acids as carcinogens in human gastrointestinal cancersMutation Research - Reviews in Mutation Research, 2005
- PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitisGut, 2004
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987